6.18.2004

SOURCE: Cognitive Labs (Preview - Monday wire service)

Cognitive Labs Announces MemCheck Service in Support of Early Detection and Tracking of Cognitive Decline

IRVINE, CA - June 21, 2004 Cognitive Labs, a developer of Internet technologies for screening and monitoring cognitive performance, today announced that it had administered its 20 millionth keystroke response.

"Achieving such a vast number of data responses is a key milestone for our company," said Managing Director Michael Addicott, "we believe no other company in our field has accomplished this goal or developed this level of trust with consumers, clinical researchers and licensees. Today, we are fortunate to be regarded as a leader in our industry, based on our success in administering our services to a global customer base."

Coupled with this milestone, the company recently announced the general availability of MemCheck (TM) a suite of user-friendly applications incorporating proprietary and patented technologies that enable users to screen and monitor their memory and mental performance and stay alert for the onset of conditions such as Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD); conditions that experts predict will affect up to 15 million people in the U.S. within a few years, and up to 40 million people worldwide.

Visitors to cognitivecare.com, the company's test-administration site can purchase an annual subscription to MemCheck and access all services for $69.95 per year. For $9.95 per month, subscribers get MemCheck and MemWatch, helping them perform periodic check-ups of their memory while comparing their results to a baseline of scores from an ever-increasing number of users, approaching 60,000 while since inception the company has attracted more than 1 million members.

About Cognitive Labs

Cognitive Labs (CL), a privately held company, develops, licenses, and markets software-based services including MemCheck and MemWatch for screening, monitoring, and averting conditions that affect human cognition and motor performance. The company offers subscriptions and software licenses, and tools for efficacy monitoring for individuals, media, government, healthcare, special education, and industrial clients. The company has been awarded U.S. patents on its technology and method, administered nearly a million tests since its inception, and been subject to numerous validity studies on its technology at world-class universities.

Contact:

Cognitive Labs
2102 Business Center Drive
Irvine, CA 92612
news@cognitivelabs.com


This page is powered by Blogger. Isn't yours?